Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success
AbstractTo provide an adequate therapeutic effect against onychomycosis, it has been suggested that topical drugs should have two properties: drug permeability through the nail plate and into the nail bed, and retention of their antifungal activity in the disease-affected areas. Only recently has the importance of other delivery routes (such as subungual) been discussed. Efinaconazole has been shown to have a more potent antifungal activity in vitro than the most commonly used onychomycosis treatments. The low keratin affinity of efinaconazole contributes to its effective delivery through the nail plate and retention of its antifungal activity. Its unique low surface tension formulation provides good wetting properties affording drug delivery both through and under the nail. High antifungal drug concentrations have been demonstrated in the nail of onychomycosis patients, and effectiveness of efinaconazole topical solution, 10% confirmed in two large well-controlled multicenter Phase 3 clinical studies in patients with mild-to-moderate disease. View Full-Text
Share & Cite This Article
Pollak, R.A.; Siu, W.J.J.; Tatsumi, Y.; Pillai, R. Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success. J. Fungi 2015, 1, 107-114.
Pollak RA, Siu WJJ, Tatsumi Y, Pillai R. Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success. Journal of Fungi. 2015; 1(2):107-114.Chicago/Turabian Style
Pollak, Richard A.; Siu, William J.J.; Tatsumi, Yoshiyuki; Pillai, Radhakrishnan. 2015. "Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success." J. Fungi 1, no. 2: 107-114.